Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies - Schedule of Potentially Dilute Loss Per Share (Details)

v3.24.1.1.u2
Basis of Presentation and Significant Accounting Policies - Schedule of Potentially Dilute Loss Per Share (Details) - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 5,935,805 11,851,544
Series A preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 3,146 190,994
Series B preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 33,883 2,047,359
Series C preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 9,346 560,757
Series D preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 0 2,289,247
Series E preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 0 5,000,000
Convertible notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 0 216,530
Series F preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 501,579 0
Series F-1 preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 72,631 0
Series F-2 preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 124,946 0
Warrants to purchase common stock (excluding penny warrants)    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 2,470,078 599,576
Warrants to purchase Series E preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 750,000 750,000
Options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 632,779 157,058
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 1,124,527 8,299
Commitment shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 212,890 31,724